Gastroenteritis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers
Conditions:   Rotavirus Infections;   Rotavirus Gastroenteritis Interventions:   Biological: Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine;   Biological: High dose Recombinant Trivalent Subunit Rotavirus Vaccine;   Biological: Placebo Sponsors:   MAXVAX Biotechnology Limited Liability Company;   Henan Center for Disease Control and Prevention Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2022 Category: Research Source Type: clinical trials